The PE Ratio as of December 2025 (TTM) for Emmessar Biotech & Nutrition Limited (EMMESSA.BO) is 66.36

According to Emmessar Biotech & Nutrition Limited’s latest financial reports and current stock price. The company's current PE Ratio is 66.36. This represents a change of -28.26% compared to the average of 92.50 of the last 4 quarters.

Emmessar Biotech & Nutrition Limited (EMMESSA.BO) Historical PE Ratio (quarterly & annually)

How has EMMESSA.BO PE Ratio performed in the past?

The mean historical PE Ratio of Emmessar Biotech & Nutrition Limited over the last ten years is 16.98. The current 66.36 PE Ratio has changed 38.98% with respect to the historical average. Over the past ten years (40 quarters), EMMESSA.BO's PE Ratio was at its highest in in the September 2015 quarter at 1.34K. The PE Ratio was at its lowest in in the December 2022 quarter at -153.01.

Emmessar Biotech & Nutrition Limited (EMMESSA.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Emmessar Biotech & Nutrition Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Emmessar Biotech & Nutrition Limited (EMMESSA.BO) Average PE Ratio

How has EMMESSA.BO PE Ratio performed in the past?

The current PE Ratio of Emmessar Biotech & Nutrition Limited (EMMESSA.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Emmessar Biotech & Nutrition Limited (EMMESSA.BO) PE Ratio vs. Peers

How is EMMESSA.BO’s PE Ratio compared to its peers?

Emmessar Biotech & Nutrition Limited’s PE Ratio is greater than Desh Rakshak Aushdhalaya Ltd. (31.95), greater than Cian Healthcare Limited (-0.62), greater than Norris Medicines Limited (-12.71), greater than Parmax Pharma Limited (-4.54), greater than Beryl Drugs Limited (49.41), less than Novateor Research Laboratories (0), greater than Chemo Pharma Laboratories Limited (-1.68), greater than Vanta Bioscience Limited (-2.13), greater than Evoq Remedies Limited (4.38), greater than Colinz Laboratories Limited (22.83),

Build a custom stock screener for Emmessar Biotech & Nutrition Limited (EMMESSA.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emmessar Biotech & Nutrition Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Emmessar Biotech & Nutrition Limited (EMMESSA.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Emmessar Biotech & Nutrition Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.